BIOA
Bioage Labs Inc
NASDAQ · Pharmaceuticals
$20.73
+0.75 (+3.75%)
Open$20.22
Previous Close$19.98
Day High$21.17
Day Low$19.54
52W High$24.00
52W Low$2.88
Volume—
Avg Volume657.3K
Market Cap865.53M
P/E Ratio—
EPS$-2.04
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
-36.6% upside
Current
$20.73
$20.73
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 148.13M | 155.08M | 129.49M |
| Net Income | 34.83M | 38.64M | 27.42M |
| Profit Margin | 23.5% | 24.9% | 21.2% |
| EBITDA | 58.57M | 58.31M | 46.56M |
| Free Cash Flow | 41.37M | 59.47M | 31.55M |
| Rev Growth | -6.9% | -7.9% | +7.7% |
| Debt/Equity | 0.90 | 0.74 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |